Back

Soluble guanylate cyclase in heart failure: A network meta-analysis and subgroup analyses of reduced and preserved ejection fraction.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Pharmacological therapy in heart failure (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mahmoud Ibrahim

McLaren Flint Hospital, Flint (United States of America)

6 More presentations in this session

Presentation thumbnail
Initiation, titration, and discontinuation - utilization of heart failure medicines in England (EVOLUTION HF UK)
Doctor R. Zhang (London, GB)
Abstract Slides Video
Presentation thumbnail
Statin and risk of dementia in patients with heart failure
Mrs Q. Ren (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Feasibility, efficacy and safety of early and rapid initiation of evidence-based treatment for patients with HFrEF- a real world experience of the "four drugs in four weeks" strategy
Doctor S. Sze (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Impact of pharmacological treatment for heart failure after myocardial recovery in arrhythmia-induced cardiomyopathy.
Mr L. Dominguez Rodriguez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
Professor L. Lund (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacological therapy in heart failure (2)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources